ArticleFrontiers in endocrinology2026
Dual nomograms to predict central and lateral cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: a two-cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In papillary thyroid carcinoma (PTC) patients with suspected Hashimoto's thyroiditis (HT) indicated by elevated preoperative thyroglobulin antibodies (TgAb) and thyroid peroxidase antibodies (TPOAb), reactive lymphadenopathy can mimic metastatic disease on imaging. This overlap complicates preoperative cervical lymph node assessment and may lead to either unnecessary dissection or missed metastases. We aimed to develop and validate separate nomograms to predict central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM) in PTC patients with concurrent HT. Methods: We retrospectively enrolled 660 PTC patients with preoperatively confirmed HT who underwent thyroid surgery in Ward A of Ningbo No. 2 Hospital (training cohort). Independent predictors of CLNM and LLNM were identified using univariate analyses followed by multivariable logistic regression, and two nomograms were constructed. An independent cohort of 459 patients from Ward B served as an external validation set. Model discrimination, calibration, and clinical utility were assessed using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analysis (DCA), respectively. Results: For CLNM, age, calcification, capsular status, and maximum tumor diameter (MTD) were independent predictors. For LLNM, tumor margins, capsular status, and MTD were independent predictors. In the training cohort, the CLNM nomogram achieved an AUC of 0.760 and the LLNM nomogram an AUC of 0.864. Both models showed good calibration and favorable net benefit on DCA. External validation confirmed stable performance (AUC 0.726 for CLNM; 0.832 for LLNM). Conclusion: We developed and externally validated two practical nomograms based on readily available preoperative clinical and ultrasonographic features to estimate CLNM and LLNM risk in PTC patients with concurrent HT. These tools may support preoperative risk stratification and help tailor the extent of neck dissection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.